Neurogenic factors in human hypertension: mechanism or myth?
D000804:Angiotensin II / Q000502:physiology; D001794:Blood Pressure; D002395:Catecholamines / Q000096:biosynthesis; D055598:Chemical Phenomena; D002621:Chemistry; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000503:physiopathology; D006977:Hypertension, Renal / Q000378:metabolism; D008297:Male; D009422:Nervous System Diseases / Q000150:complications*; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D005082:Physical Exertion; D011187:Posture; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology / Q000503:physiopathology; D014316:Tritium
D002395:Catecholamines; D014316:Tritium; D000804:Angiotensin II; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline; D009638:Norepinephrine; D004837:Epinephrine